losartan-potassium and Rheumatic-Heart-Disease

The authors present results of using recombinant human erythropoietin in patients operated on the heart under conditions of extracorporeal blood circulation. It was found that the intravenous infusions of erythropoietin at the postoperative period accelerated the restitution of circulating erythron indices. The volume of transfusion of the donor erythrocyte-containing media to the patient is given erythropoietin was reliably less than that in the control group. The results obtained allow using erythropoietin to be recommended as an effective method of prophylactics and treatment of anemia in cardiosurgical patients.

Topics: Adult; Anemia; Cardiac Surgical Procedures; Endocarditis, Bacterial; Erythropoietin; Extracorporeal Circulation; Female; Heart Defects, Congenital; Humans; Hypothermia, Induced; Male; Postoperative Care; Postoperative Complications; Recombinant Proteins; Rheumatic Heart Disease

Topics: Adult; Aged; Aged, 80 and over; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cardiac Surgical Procedures; Christianity; Coronary Artery Bypass; Erythropoietin; Female; Heart Septal Defects, Atrial; Humans; Hypertension, Pulmonary; Middle Aged; Mitral Valve Insufficiency; Myocardial Infarction; Pulmonary Valve Stenosis; Religion and Medicine; Rheumatic Heart Disease; Tricuspid Valve Insufficiency

Topics: Coronary Disease; Epoetin Alfa; Erythropoietin; Heart Failure; Hematocrit; Humans; Immunization, Passive; Leukocyte Count; Pulmonary Heart Disease; Reticulocytes; Rheumatic Heart Disease; Serum